Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists have become the fastest-growing weight loss and diabetes treatment class, with clinical trials showing average weight reductions of 15–22% over 68 weeks. These medications work by signaling your brain to eat less, slow stomach emptying, and regulate blood sugar—making them effective for both type 2 diabetes and weight management. Understanding how GLP-1 drugs function can help you decide if personalized GLP-1 therapy is right for your health goals.
What Is a GLP-1 Agonist and How Does It Work?
GLP-1 stands for glucagon-like peptide-1, a natural hormone your intestines produce after eating. GLP-1 agonists are medications designed to mimic this hormone's action, attaching to GLP-1 receptors in your brain and pancreas. When activated, these receptors trigger a cascade of signals: reduced hunger, increased feelings of fullness, slower gastric emptying, and improved insulin secretion in response to meals. The net result is lower calorie intake, more stable blood sugar, and gradual, sustainable weight loss.
The mechanism differs fundamentally from older weight loss drugs like phentermine, which simply boost energy and suppress appetite through stimulant pathways. GLP-1 agonists address the root biological drivers of hunger—the hormonal and neural circuits that regulate satiety and glucose homeostasis. This is why patients often report that food cravings fade naturally rather than feeling forced to restrict themselves. Clinical data consistently shows that GLP-1 agonists produce durable weight loss even after dose stabilization, suggesting a true metabolic recalibration rather than a temporary appetite-suppression effect.
GLP-1 Drugs for Type 2 Diabetes and Weight Management
GLP-1 agonists have dual approval for both type 2 diabetes and chronic weight management, though the approved doses and indications may differ. In diabetes patients, GLP-1 drugs reduce HbA1c (blood sugar average) by 1.0–1.8%, often allowing reductions in other diabetes medications. For weight management in people without diabetes, the same compounds at higher doses produce average weight losses of 15–22% of body weight over 68 weeks. Many patients benefit from both effects simultaneously—improved metabolic control plus substantial weight reduction—which helps prevent or delay diabetes progression.
The cardiovascular outcomes are equally compelling: patients using GLP-1 agonists show reduced rates of heart attacks, strokes, and cardiovascular death in large trials. This cardioprotective effect extends beyond weight loss alone, suggesting these drugs directly benefit heart and blood vessel health. For this reason, GLP-1 agonists are now recommended not only for weight loss but also as part of heart disease prevention in people with obesity and additional cardiovascular risk factors.
Semaglutide vs. Tirzepatide: Comparing GLP-1 Treatment Options
Semaglutide (the active compound in branded Ozempic and Wegovy) is a GLP-1-only agonist—it activates GLP-1 receptors exclusively. Tirzepatide (active compound in Mounjaro and Zepbound) is a dual agonist, activating both GLP-1 and GIP receptors simultaneously. Clinical head-to-head trials show tirzepatide produces slightly greater average weight loss (22% vs. 15–17% with semaglutide) and greater HbA1c reduction in diabetes patients. However, both are highly effective, and individual response varies based on genetics, lifestyle, and adherence.
PlexusDx offers compounded semaglutide injection starting at $149/month and compounded tirzepatide injection starting at $249/month across all commitment tiers. For patients who prefer oral tablets, oral semaglutide starts at $249/month and oral tirzepatide at $279/month. Your dose may need to go up as your body adjusts, but your price won't—PlexusDx maintains flat monthly pricing regardless of dose level. The Precision Peptide Genetic Test ($99 add-on after your first month) can help identify which pathway your body responds to most strongly, guiding your provider to select the optimal compound for you.
Common Side Effects and Safety Considerations
The most frequently reported side effects of GLP-1 agonists are gastrointestinal: nausea, vomiting, diarrhea, and constipation, especially during dose escalation. These effects tend to be mild to moderate, temporary, and manageable with slower dosing schedules and dietary adjustments. Serious side effects are rare but include pancreatitis, gallbladder disease, and thyroid tumors (in animal studies; no confirmed human cases). People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should not use GLP-1 agonists.
Dehydration risk increases slightly on GLP-1 therapy due to reduced food and fluid intake, so adequate water consumption is essential. Some patients experience fatigue or muscle aches during initial weeks, which typically resolves as the body adapts. All medications from PlexusDx are compounded in licensed 503A pharmacies under strict quality standards, and your care provider monitors you regularly to catch any adverse effects early. Serious complications are uncommon when therapy is managed by a qualified clinician with appropriate patient follow-up.
Personalized GLP-1 Therapy and Genetic Testing at PlexusDx
Not all patients respond identically to GLP-1 agonists—some achieve dramatic weight loss while others see more modest results. This variation stems partly from genetic differences in GLP-1 and GIP receptor function, appetite regulation pathways, and fat storage genes. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights, including key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313. These variants influence how strongly your body responds to GLP-1 stimulation, energy balance regulation, and weight gain predisposition.
By mapping your peptide-pathway genetics, PlexusDx providers can personalize your medication selection, dosing strategy, and supportive interventions before you begin or optimize ongoing therapy. Patients with certain GLP1R genetic profiles may respond powerfully to semaglutide, while others benefit more from tirzepatide's dual-agonist approach. The Precision Peptide Genetic Test costs $99 and is available as an add-on after your first month of treatment, making it an affordable way to shift the odds in your favor. This level of genetic personalization transforms GLP-1 therapy from a one-size-fits-most approach into precision medicine tailored to your unique biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How quickly will I lose weight on a GLP-1 agonist?
Most patients begin noticing reduced appetite within days to weeks of starting therapy, but significant weight loss typically emerges over 8–12 weeks as doses are titrated upward. Average weight loss in clinical trials was 1–2 pounds per week after reaching therapeutic doses, though individual timelines vary. PlexusDx providers personalize your dosing schedule to balance efficacy with tolerability, so you can progress at a safe, sustainable pace.
What is the difference between GLP-1 and GIP, and why does it matter?
GLP-1 and GIP are two distinct hormonal pathways that regulate appetite and glucose metabolism. Tirzepatide activates both (dual agonist), while semaglutide activates GLP-1 alone. Clinical trials show tirzepatide produces slightly greater average weight loss, but semaglutide remains highly effective—the best choice depends on your genetics and individual response profile, which the Precision Peptide Genetic Test can help clarify.
Can I use PlexusDx GLP-1 medications without insurance?
Yes. PlexusDx serves all 50 states with no insurance required and no membership fees. Compounded semaglutide injection starts at $149/month, and all medications are HSA/FSA eligible, making them accessible regardless of your insurance status or plan type.
Are compounded GLP-1 medications from PlexusDx as safe as branded versions?
PlexusDx compounds all medications in licensed 503A pharmacies under strict FDA oversight and pharmaceutical standards. While compounded medications are not FDA-approved as branded drugs are, 503A compounding is legal and widely used for patient access and affordability. Your PlexusDx provider monitors you regularly to ensure safety and efficacy, just as with any prescription medication.
What can the Precision Peptide Genetic Test tell me about my GLP-1 response?
The Precision Peptide Genetic Test analyzes variants in GLP-1 receptor, GIP receptor, appetite control, and fat metabolism genes to predict how strongly your body will respond to each medication type and identify genetic predispositions to weight gain. This $99 add-on after your first month helps your provider optimize your therapy selection and dosing, transforming GLP-1 treatment from trial-and-error into precision medicine personalized to your genetic blueprint.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Do You Give Yourself a Shot of Ozempic Properly
How Much Do You Have to Weigh to Get Ozempic?